Rhizome AI

Rhizome AI is a Y Combinator-backed company that agent Platform for Life Sciences. The company participated in the Winter 2026 batch of Y Combinator.

It takes 500,000 days of office work to bring a drug to market. We want to make it 5. To get there, we need agents doing most of the work.

Today, our research agent is the best way to know what the FDA thinks. Users ask a question and get an answer backed by up to 1,000 documents, where each statement has a citation.

It's the best because we have the best retrieval engine. We've tuned it on our life science-specific dataset, and we find what others miss.

Rhizome AI was part of Y Combinator's Winter 2026 cohort, has a team of approximately 1 employees, and is actively operating.